Načítá se...
Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
BACKGROUND: To evaluate the transmembrane clearance (CL(TM)) of apixaban during modeled in vitro continuous renal replacement therapy (CRRT), assess protein binding and circuit adsorption, and provide initial dosing recommendations. METHODS: Apixaban was added to the CRRT circuit and serial pre-filt...
Uloženo v:
| Vydáno v: | BMC Nephrol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7847018/ https://ncbi.nlm.nih.gov/pubmed/33516188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-021-02248-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|